Oral Azacitidine Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

Virginia Commonwealth University1
Bristol-Myers Squibb1
Alliance for Clinical Trials in Oncology1

Indications

Cancer3
Acute Myeloid Leukemia2
Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma1
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma1
Enteropathy-associated T-cell Lymphoma1

Other1 trial

A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia

Little Rock, Arkansas1 trial

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

University of Arkansas for Medical Sciences

Phase 2

Richmond, Virginia1 trial

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Virginia Commonwealth University

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.